These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 34297745)

  • 1. Inhibition of polo-like kinase 1 (PLK1) facilitates reactivation of gamma-herpesviruses and their elimination.
    Biswas A; Zhou D; Fiches GN; Wu Z; Liu X; Ma Q; Zhao W; Zhu J; Santoso NG
    PLoS Pathog; 2021 Jul; 17(7):e1009764. PubMed ID: 34297745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STAT3 Regulates Lytic Activation of Kaposi's Sarcoma-Associated Herpesvirus.
    King CA; Li X; Barbachano-Guerrero A; Bhaduri-McIntosh S
    J Virol; 2015 Nov; 89(22):11347-55. PubMed ID: 26339061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Polo-like kinase 1 (PLK1) facilitates the elimination of HIV-1 viral reservoirs in CD4
    Zhou D; Hayashi T; Jean M; Kong W; Fiches G; Biswas A; Liu S; Yosief HO; Zhang X; Bradner J; Qi J; Zhang W; Santoso N; Zhu J
    Sci Adv; 2020 Jul; 6(29):eaba1941. PubMed ID: 32832623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KSHV reactivation from latency requires Pim-1 and Pim-3 kinases to inactivate the latency-associated nuclear antigen LANA.
    Cheng F; Weidner-Glunde M; Varjosalo M; Rainio EM; Lehtonen A; Schulz TF; Koskinen PJ; Taipale J; Ojala PM
    PLoS Pathog; 2009 Mar; 5(3):e1000324. PubMed ID: 19266083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of Kaposi's sarcoma-associated herpesvirus (KSHV) by inhibitors of class III histone deacetylases: identification of sirtuin 1 as a regulator of the KSHV life cycle.
    Li Q; He M; Zhou F; Ye F; Gao SJ
    J Virol; 2014 Jun; 88(11):6355-67. PubMed ID: 24672028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and Subcellular Localization of the Kaposi's Sarcoma-Associated Herpesvirus K15P Protein during Latency and Lytic Reactivation in Primary Effusion Lymphoma Cells.
    Smith CG; Kharkwal H; Wilson DW
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28835496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KRAB-ZFP Repressors Enforce Quiescence of Oncogenic Human Herpesviruses.
    Li X; Burton EM; Koganti S; Zhi J; Doyle F; Tenenbaum SA; Horn B; Bhaduri-McIntosh S
    J Virol; 2018 Jul; 92(14):. PubMed ID: 29695433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutual inhibition between Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus lytic replication initiators in dually-infected primary effusion lymphoma.
    Jiang Y; Xu D; Zhao Y; Zhang L
    PLoS One; 2008 Feb; 3(2):e1569. PubMed ID: 18253508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EBV and KSHV Infection Dysregulates Autophagy to Optimize Viral Replication, Prevent Immune Recognition and Promote Tumorigenesis.
    Cirone M
    Viruses; 2018 Oct; 10(11):. PubMed ID: 30384495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. De novo protein synthesis is required for lytic cycle reactivation of Epstein-Barr virus, but not Kaposi's sarcoma-associated herpesvirus, in response to histone deacetylase inhibitors and protein kinase C agonists.
    Ye J; Gradoville L; Daigle D; Miller G
    J Virol; 2007 Sep; 81(17):9279-91. PubMed ID: 17596302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptome analysis of Kaposi's sarcoma-associated herpesvirus during de novo primary infection of human B and endothelial cells.
    Purushothaman P; Thakker S; Verma SC
    J Virol; 2015 Mar; 89(6):3093-111. PubMed ID: 25552714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like receptor signaling controls reactivation of KSHV from latency.
    Gregory SM; West JA; Dillon PJ; Hilscher C; Dittmer DP; Damania B
    Proc Natl Acad Sci U S A; 2009 Jul; 106(28):11725-30. PubMed ID: 19564611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kaposi's sarcoma-associated herpesvirus-induced angiogenin plays roles in latency via the phospholipase C gamma pathway: blocking angiogenin inhibits latent gene expression and induces the lytic cycle.
    Sadagopan S; Valiya Veettil M; Paudel N; Bottero V; Chandran B
    J Virol; 2011 Mar; 85(6):2666-85. PubMed ID: 21209106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myc is required for the maintenance of Kaposi's sarcoma-associated herpesvirus latency.
    Li X; Chen S; Feng J; Deng H; Sun R
    J Virol; 2010 Sep; 84(17):8945-8. PubMed ID: 20573831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting FoxO proteins induces lytic reactivation of KSHV for treating herpesviral primary effusion lymphoma.
    Lan J; Wang Y; Yue S; Xu D; Li Y; Peng X; Hu J; Ju E; He S; Li T
    PLoS Pathog; 2023 Aug; 19(8):e1011581. PubMed ID: 37594999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonsense-mediated decay controls the reactivation of the oncogenic herpesviruses EBV and KSHV.
    van Gent M; Reich A; Velu SE; Gack MU
    PLoS Biol; 2021 Feb; 19(2):e3001097. PubMed ID: 33596193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus (EBV) Rta-mediated EBV and Kaposi's sarcoma-associated herpesvirus lytic reactivations in 293 cells.
    Chen YJ; Tsai WH; Chen YL; Ko YC; Chou SP; Chen JY; Lin SF
    PLoS One; 2011 Mar; 6(3):e17809. PubMed ID: 21423768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone Marrow-Derived SH-SY5Y Neuroblastoma Cells Infected with Kaposi's Sarcoma-Associated Herpesvirus Display Unique Infection Phenotypes and Growth Properties.
    Kong X; Li D; Mansouri A; Kang G; Sayood K; West J; Wood C
    J Virol; 2021 Jun; 95(13):e0000321. PubMed ID: 33853962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cdk1 inhibition induces mutually inhibitory apoptosis and reactivation of Kaposi's sarcoma-associated herpesvirus.
    Li X; Chen S; Sun R
    J Virol; 2012 Jun; 86(12):6668-76. PubMed ID: 22496227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication Is Independent of Anaphase-Promoting Complex Activity.
    Elbasani E; Gramolelli S; GĂŒnther T; Gabaev I; Grundhoff A; Ojala PM
    J Virol; 2020 Jun; 94(13):. PubMed ID: 32295923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.